Source Natural Foods & Herbal Supplements Hits 52-Week High, Outperforms Sector by 4.63%
Source Natural Foods & Herbal Supplements, a microcap company in the pharmaceuticals and drugs industry, has reached a new milestone with its stock price hitting a 52-week high of Rs. 247 on October 15, 2024. The stock has outperformed the sector by 4.63% and has been on a consecutive gain streak for the past 5 days, with a 23.1% increase in returns. The company's consistent trading at Rs. 247 and its impressive 1-year return of 159.49% showcase its strong growth potential and ability to outperform the market.
Source Natural Foods & Herbal Supplements, a microcap company in the pharmaceuticals and drugs industry, has recently reached a new milestone. On October 15, 2024, the company's stock price hit a 52-week high of Rs. 247. This news has caught the attention of investors and market analysts, with MarketsMOJO giving a 'Hold' rating for the stock.
The stock's performance today has been impressive, outperforming the sector by 4.63%. It has also been on a consecutive gain streak for the past 5 days, with a 23.1% increase in returns during this period. The stock opened with a gap up of 4.99% and reached an intraday high of Rs. 247.
What's interesting to note is that the stock has been trading at a consistent price of Rs. 247 since its opening, indicating a strong hold in the market. In fact, Source Natural is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In terms of overall performance, Source Natural Foods & Herbal Supplements has shown an impressive 1-year return of 159.49%, compared to the Sensex's 23.98% performance. This showcases the company's strong growth potential and its ability to outperform the market.
As a microcap company, Source Natural Foods & Herbal Supplements may not be on the radar of many investors. However, its recent achievements and consistent performance make it a stock worth considering. With a 'Hold' rating from MarketsMOJO, it will be interesting to see how the company continues to grow and make its mark in the pharmaceuticals and drugs industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
